Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „thromboembolic“
Suchtreffer
Begriffe & Kennungen
Advagraf · 4.8 · Vascular disorders very common: hypertension common: thromboembolic and ischaemic events, vascular hypotensive
Eintrag öffnenAfqlir · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAfqlir · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAfqlir · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAfqlir · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAhzantive · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAhzantive · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAhzantive · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAhzantive · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAlprolix · 4.8 · There is a potential risk of thromboembolic episodes following the administration of factor IX products, with
Eintrag öffnenAranesp · 4.8 · Identified adverse reactions associated with Aranesp are hypertension, stroke, thromboembolic events, convulsi
Eintrag öffnenArixtra · 4.8 · 6 - 425 medical patients who are at risk for thromboembolic complications treated up to 14 days (Arixtra 1.5 m
Eintrag öffnenAvastin · 4.8 · 18 Patients who have experienced a venous thromboembolic reaction may be at higher risk for a recurrence if th
Eintrag öffnenAvastin · 4.8 · Arterial thromboembolism: An increased incidence of arterial thromboembolic reactions was observed in patients
Eintrag öffnenAvastin · 4.8 · Grade 3-5 (NCI-CTCAE v.3) venous thromboembolic reactions have been reported in up to 7.8% of patients treated
Eintrag öffnenAvastin · 4.8 · In clinical trials across indications, the overall incidence of venous thromboembolic reactions ranged from 2.
Eintrag öffnenAvastin · 4.8 · In clinical trials, the overall incidence of arterial thromboembolic reactions ranged up to 3.8% in the Avasti
Eintrag öffnenAvastin · 4.8 · Venous thromboembolism: The incidence of venous thromboembolic reactions in clinical trials was similar in pat
Eintrag öffnenBaiama · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenBaiama · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnen